Patents for C12N 5 - Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor (182,629)
12/2000
12/26/2000US6165783 Inducing the cellular differentiation of neuronal stem cells into neurons; incubating neuronal stem cells with glycoproteins and animal growth regulators and allowing stem cells to differentiate into neurons
12/26/2000US6165782 Nucleotide sequences for the transfer of heterologous nucleotide sequences to cells and biosynthesis of transcripts and heterologous proteins
12/26/2000US6165771 Compounds
12/26/2000US6165767 Protein phosphatase-related molecules
12/26/2000US6165766 Amino acid sequence of serine/threonine protein kinase; anticarcinogenic/antiarthritic/antiinflammatory agents; treatment of osteoporosis, adult respiratory disease syndrome, inflammatory bowel disease, eating disorders; diagnosis
12/26/2000US6165763 Nucleotide and amino acid sequences of enzyme from streptococcus; for drug screening of bacteriostats and bactericides
12/26/2000US6165760 Amino acid sequence of polypeptide of the glutamyl transfer rna synthetase family; drug screening of bacteriostats and bactericides; vaccines; diagnosis of infections
12/26/2000US6165753 Cyclin E genes and proteins
12/26/2000US6165752 Expression system which produces polypeptide of defined amino acid sequence when present in a cell; diagnosis and therapy for creutzfeldt-jakob disease and nervous system disorders; anticarcinogenic agents
12/26/2000US6165751 HLDAT86 polynucleotides
12/26/2000US6165748 Useful in the modulation of cellular formation, growth, differentiation, proliferation and/or maintenance of a variety of adult and embryonic tissues and organs
12/26/2000US6165732 Drug screening by using lipid bilayer that has potassium- or chloride-selective channel formed from polpeptide of bcl-2 family, contacting compound with bilayer, and determining ion-selectivity of channel; indicates agonist or antagonist
12/26/2000US6165720 Conjugating nucleic acid with a peptide nucleic acid in a sequence-specific manner prior to transfection, transfecting cell with conjugate, and monitoring intracellular location
12/26/2000US6165496 A sheet formed of cross-linked keratin not requiring a binding agent, bound together by reformed disulfide linkage and hydrogen bond, used as wound healing dressing, preferred use is as tissue engineering cell scaffold for grafting
12/26/2000US6165487 Useful for treatment of tissue defects in tissues such as bone, cartilage, and muscle.
12/26/2000US6165476 Fusion proteins with an immunoglobulin hinge region linker
12/26/2000US6165465 Immunologic enhancement of the somatogenic effect of somatotropin with an antibody
12/26/2000US6165464 Monoclonal antibodies directed to the HER2 receptor
12/26/2000US6165461 Tao protein kinases and methods of use therefor
12/26/2000US6165459 Methods for suppressing myeloid cells with chemokines
12/26/2000US6164012 Hydrogel comprising a polyester polyurethane polyurea terpolymer, at least one polysaccharide, and biological material such as plant cells or plant embryos; sterile, for protecting the material during storage, handling
12/21/2000WO2000077262A1 Synthetic ligation reassembly in directed evolution
12/21/2000WO2000077256A1 48 human secreted proteins
12/21/2000WO2000077237A1 49 human secreted proteins
12/21/2000WO2000077236A2 Methods for enhancing the production of cytokines in cell cultur e
12/21/2000WO2000077233A2 Complement-resistant non-mammalian dna viruses and uses thereof
12/21/2000WO2000077230A1 High-efficiency agrobacterium-mediated transformation of cotton using petiole explants
12/21/2000WO2000077229A2 R1 protein from wheat and the use thereof for the production of modified strach
12/21/2000WO2000077226A1 22025, a novel human cyclic nucleotide phosphodiesterase
12/21/2000WO2000077221A1 Hyaluronidase from the hirudinaria manillensis, isolation, purification and recombinant method of production
12/21/2000WO2000077214A2 Characterization of the yeast transcriptome
12/21/2000WO2000077208A2 Gustatory receptors in drosophila
12/21/2000WO2000077207A2 Nucleic acid encoding proteins involved in protein degradation, products and methods related thereto
12/21/2000WO2000077206A2 The myostatin gene promoter and inhibition of activation thereof
12/21/2000WO2000077203A1 Lipocalin family protein
12/21/2000WO2000077199A1 Cloning and expression of a novel 5-ht4 receptor
12/21/2000WO2000077198A2 Identification and molecular characterisation of proteins, expressed in the tick salivary glands
12/21/2000WO2000077197A1 47 human secreted proteins
12/21/2000WO2000077196A1 Gene and protein sequences of phage t4 gene 35
12/21/2000WO2000077191A1 Tumor necrosis factor related receptor, tr6
12/21/2000WO2000077182A1 Nucleic acid fragment and vector containing halogenase and method for the halogenation of chemical compounds
12/21/2000WO2000077179A2 Human poly(adp-ribose) polymerase 2 materials and methods
12/21/2000WO2000077175A1 Process of expressing and isolating recombinant proteins and recombinant protein products from plants, plant derived tissues or cultured plant cells
12/21/2000WO2000077174A1 Process of expressing and isolating recombinant proteins and recombinant protein products from plants, plant derived tissues or cultured plant cells
12/21/2000WO2000077173A1 42 human secreted proteins
12/21/2000WO2000077170A2 Ex-vivo propagation of kidney
12/21/2000WO2000077168A2 ANTAGONISTS OF BMP AND TGFβ SIGNALLING PATHWAYS
12/21/2000WO2000077166A2 Gene expression modulated in gastrointestinal inflammation
12/21/2000WO2000077046A1 A male-specific protein homologue involved in histocompatability
12/21/2000WO2000077040A2 Human intracellular signaling molecules
12/21/2000WO2000077037A2 Secreted and transmembrane polypeptides and nucleic acids encoding the same
12/21/2000WO2000077035A2 Novel potassium channels and genes encoding these potassium channels
12/21/2000WO2000077028A1 Retro-inverso peptides derived from interleukin-3
12/21/2000WO2000077026A1 49 human secreted proteins
12/21/2000WO2000077023A1 48 human secreted proteins
12/21/2000WO2000077022A1 50 human secreted proteins
12/21/2000WO2000077021A1 48 human secreted proteins
12/21/2000WO2000076553A1 Use of viral vectors and charged molecules for gene therapy
12/21/2000WO2000076542A1 Use of antibodies against cd20 for the treatment of the graft versus host disease
12/21/2000WO2000076540A2 Streptococcus pneumoniae proteins and vaccines
12/21/2000WO2000076537A2 Use of semi-allogeneic cell line-peptide complexes for the treatment of cancer, aids and other viral diseases
12/21/2000WO2000076531A1 47 human secreted proteins
12/21/2000WO2000076530A1 49 human secreted proteins
12/21/2000WO2000076527A2 New molecular complexes presenting high affinity binding with respect to monocyte derived cells and their uses in therapy
12/21/2000WO2000076320A1 Generation of antigen specific t suppressor cells for treatment of rejection
12/21/2000WO2000076310A1 Transgenic animals for producing specific isotypes of human antibodies via non-cognate switch regions
12/21/2000WO2000076308A1 Animal models and methods for analysis of lipid metabolism and screening of pharmaceutical and pesticidal agents that modulate lipid metabolism
12/21/2000WO2000066736B1 Growth factor homolog zvegf4
12/21/2000WO2000055312A3 Rt-pcr of clonal neurospheres
12/21/2000WO2000053628A3 Genes encoding human potassium channel proteins
12/21/2000WO2000052187A3 Enhanced system for construction of adenovirus vectors
12/21/2000WO2000052056A3 Anti-plasmodium compositions and methods of use
12/21/2000WO2000050596A3 14273 receptor, a novel g-protein coupled receptor
12/21/2000WO2000050062A3 Methods and compositions for altering mucus secretion
12/21/2000WO2000048642A3 Biocompatible material with a novel functionality
12/21/2000WO2000048631A3 Adjuvant and cell maturation agent
12/21/2000WO2000048621A3 Methods and compositions for regulating protein-protein interactions
12/21/2000WO2000047762A3 Enriched central nervous system cell populations
12/21/2000WO2000046240A3 Polypeptides involved in immune response
12/21/2000WO2000040701A3 Non-myeloablative tolerogenic treatment
12/21/2000WO2000035950A3 Reagents and methods useful for detecting diseases of the breast
12/21/2000EP1144671A3 Enriched central nervous system cell populations
12/21/2000DE19928210A1 Isolated neuronal cell material free of glial cells, useful for transplantation, e.g. to treat Parkinson's disease
12/21/2000DE19927575A1 Increasing resistance of crop plants to fungal or bacterial pathogens, by engineering a reduction in activity of flavanone-3-hydroxylase
12/21/2000DE19927574A1 Increasing content of flavonoids and phenols in plants, useful for e.g. preventing cardiovascular disease, by reducing activity of flavanone-3-hydroxylase
12/21/2000DE19927568A1 Increasing resistance of crop plants to chemical stress, especially herbicides, by engineering a reduction in activity of flavanone-3-hydroxylase
12/21/2000CA2751621A1 Hybridomas that undergo class-switching in vitro
12/21/2000CA2391364A1 47 human secreted proteins
12/21/2000CA2391361A1 47 human secreted proteins
12/21/2000CA2390946A1 49 human secreted proteins
12/21/2000CA2387696A1 48 human secreted proteins
12/21/2000CA2383041A1 49 human secreted proteins
12/21/2000CA2382769A1 42 human secreted proteins
12/21/2000CA2382748A1 50 human secreted proteins
12/21/2000CA2382743A1 48 human secreted proteins
12/21/2000CA2382735A1 49 human secreted proteins
12/21/2000CA2382185A1 48 human secreted proteins
12/21/2000CA2378512A1 Characterization of the yeast transcriptome
12/21/2000CA2376956A1 Charged compounds facilitate viral transduction of cells
12/21/2000CA2376717A1 Human poly(adp-ribose) polymerase 2 materials and methods